Jing Yang, Hui Li, Bei Du, Desheng Song, Nan Jin, Ruihua Wei
{"title":"Age-indexed cumulative risk of high myopia estimated from axial length and early axial elongation: a 7-year school-based longitudinal cohort study.","authors":"Jing Yang, Hui Li, Bei Du, Desheng Song, Nan Jin, Ruihua Wei","doi":"10.3389/fmed.2026.1939322","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To develop and validate age-indexed models estimating the cumulative risk of high myopia, defined as axial length (AL) ≥ 26.0 mm, using routinely collected ocular biometry, and to evaluate their potential for clinical risk stratification.</p><p><strong>Methods: </strong>This 7-year school-based longitudinal cohort included 7,052 Chinese children aged 6-16 years at baseline who participated in a school-based screening program in Tianjin, China, from 2018 to 2024. Discrete-time survival models with age as the timescale estimated cumulative risk from ages 9 to 18 years. Two models were tested: baseline AL plus sex and baseline AL plus first-year axial elongation (ΔAL) plus sex. Performance was assessed in a participant-level temporal holdout test set using iAUC, iBrier, calibration, and decision-curve analysis, and by school-level internal-external cross-validation using iAUC and iBrier.</p><p><strong>Results: </strong>Overall, 577 participants (8.2%) developed high myopia. In the temporal holdout test set (<i>n</i> = 5,245), the AL + ΔAL model outperformed the AL-only model, with higher discrimination [iAUC, 0.919 [95% CI, 0.902-0.933] vs. 0.851 [95% CI, 0.833-0.869]] and lower prediction error [iBrier, 0.074 [95% CI, 0.068-0.081] vs. 0.087 [95% CI, 0.080-0.095]]. Calibration was close to ideal, decision-curve analysis showed clinical net benefit, and school-level validation confirmed stable performance.</p><p><strong>Conclusions: </strong>Routine AL measurement, particularly when combined with early axial elongation, enables accurate age-specific risk estimation of AL-defined high myopia and provides a transparent basis for timely and proportionate myopia-control decisions.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1939322"},"PeriodicalIF":3.6000,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13677513/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2026.1939322","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To develop and validate age-indexed models estimating the cumulative risk of high myopia, defined as axial length (AL) ≥ 26.0 mm, using routinely collected ocular biometry, and to evaluate their potential for clinical risk stratification.
Methods: This 7-year school-based longitudinal cohort included 7,052 Chinese children aged 6-16 years at baseline who participated in a school-based screening program in Tianjin, China, from 2018 to 2024. Discrete-time survival models with age as the timescale estimated cumulative risk from ages 9 to 18 years. Two models were tested: baseline AL plus sex and baseline AL plus first-year axial elongation (ΔAL) plus sex. Performance was assessed in a participant-level temporal holdout test set using iAUC, iBrier, calibration, and decision-curve analysis, and by school-level internal-external cross-validation using iAUC and iBrier.
Results: Overall, 577 participants (8.2%) developed high myopia. In the temporal holdout test set (n = 5,245), the AL + ΔAL model outperformed the AL-only model, with higher discrimination [iAUC, 0.919 [95% CI, 0.902-0.933] vs. 0.851 [95% CI, 0.833-0.869]] and lower prediction error [iBrier, 0.074 [95% CI, 0.068-0.081] vs. 0.087 [95% CI, 0.080-0.095]]. Calibration was close to ideal, decision-curve analysis showed clinical net benefit, and school-level validation confirmed stable performance.
Conclusions: Routine AL measurement, particularly when combined with early axial elongation, enables accurate age-specific risk estimation of AL-defined high myopia and provides a transparent basis for timely and proportionate myopia-control decisions.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world